The Food and Drug Administration has approved the latest version of Pfizer and BioNTech's COVID-19 vaccine, the companies ...

Most investors look at the dividend payout ratio when they consider dividend safety. This metric compares dividends to ...

COVID-19 vaccine formula targets the XFG variant, in line with FDA guidance to more closely match contemporary circulating ...

Pfizer agreed to a $44 million Chantix settlement. Here's who may qualify, how to file a claim and the deadline to submit.

The new shots, available soon, are designed to protect against the dominant strain and will be covered by insurance.

In August 2026, Pfizer and BioNTech received U.S. FDA approval for their updated COMIRNATY COVID-19 vaccine targeting the XFG ...

Pfizer shares sit near a 52-week high after years of post-pandemic punishment, and now Wall Street analysts are quietly ...

Stocks that don't generate strong returns can still make good dividend investments. As long as their payouts are sustainable ...

Pfizer's cardiovascular business highlights the intersection of drug pricing, marketing, patents, and competition in the ...

A biomanufacturing facility in Everett that Pfizer decided to shut down before it opened is getting a new lease on life, with ...

Pfizer said it cut its full-year revenue expectation for its Covid products to $4 billion, down from around $5 billion previously.

Though not without a bump along the way, Roivant-backed Priovant Therapeutics has pushed its dual TYK2/JAK1 inhibitor across ...